Jeffrey M. Nugent - Chairman of the Board: Mr. Nugent has served as Chairman of the Board since . He has held various leadership positions in the healthcare industry, including CEO of Revlon, a publicly-traded global cosmetics company, and CEO of Neutrogena Corporation, a skin care company that was later acquired by Johnson & Johnson.
Jeffrey N. Howrah - President, CEO and Director: Mr. Howrah has served as CEO since , and also served as President beginning . He has more than 25 years of experience in the medical device industry, including in leadership roles at companies such as Tornier, Covidien, and Bristol-Myers Squibb.
Paul Little - Chief Financial Officer: Mr. Little has served as CFO since . Previously, he held leadership positions at several public companies, including Cardiovascular Systems, Inc., Minnetronix Inc., and Synovis Life Technologies.
Sri Sundaravadanan - Chief Technology Officer: Mr. Sundaravadanan has served as CTO since . He has more than 20 years of experience in the medical device industry, including in leadership roles at Boston Scientific, Medtronic, and Pathway Medical Technologies.
Patrick F. Williams - General Counsel and Secretary: Mr. Williams has served as General Counsel and Secretary since . He was previously the Chief Compliance Officer and Chief Legal Officer at Caligor Rx, and held executive positions at companies such as GE Capital and Johnson & Johnson.
Karen Zaderej - Director: Ms. Zaderej was appointed to the Board in . She has more than 30 years of experience in the medical device industry, including as CEO of AxoGen, a publicly-traded company that provides surgical solutions for peripheral nerve injuries.
Patrick S. Miles, Jr. - Director: Mr. Miles was appointed to the Board in . He is the CEO of Huron Valley Financial and also an active attorney, entrepreneur and investor.
Mariann Wenckebach - Director: Ms. Wenckebach was appointed to the Board in . She has more than 30 years of senior management experience in the pharmaceutical and biotech industry, including roles as President and CEO of four publicly-traded companies.
Sientra Inc currently has 242 employees.
News about Sientra Inc Key Personnel |
Sientra, a leading medical aesthetics company, has announced its intention to pursue a strategic sale of its business through a voluntary Chapter 11 process. This decision comes as the company seeks to address its financial challenges and ensure the long-term sustainability of its operations. In order to support ongoing operations during the sale process, Sientra has successfully secured $22.5 million of new financing from its existing lenders.
The decision to pursue a Chapter 11 process underscores the company s commitment to find a suitable buyer who can provide the necessary resources and expertise to drive growth and enhance shareholder value. By seeking a strategic sale, Sientra aims to positio...
|
